Novel treatment possibilities of invasive aspergillosis
Invasive aspergillosis is the leading fungal infection in patients with hematological malignancies. The review represents the incidence of invasive aspergillosis in different groups of patients, risk factors for its development, treatment options, including the new drug isavuconazole.
Saved in:
| Main Author: | G. A. Klyasova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/502 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive aspergillosis in patients with acute myeloid leukemia: difficulties in choosing first-line therapy in real clinical practice and pharmacoeconomic analysis of the feasibility of using new antifungal drugs
by: Yu. S. Osipov, et al.
Published: (2025-05-01) -
Invasive aspergillosis in children and adolescents with solid tumors: clinical cases and registry analysis
by: Yu. V. Dinikina, et al.
Published: (2019-04-01) -
Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil
by: Larissa Simão Gandolpho, et al.
Published: (2025-06-01) -
Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019)
by: Dionysios Neofytos, et al.
Published: (2024-10-01) -
Current Challenges in the Treatment of Invasive Aspergillosis in Geriatric Patients
by: Sara Fueyo Álvarez, et al.
Published: (2025-06-01)